Medicare coverage of ClonoSEQ shows market progress for next-gen sequencing
Adaptive Biotechnologies has received approval for Medicare coverage of its diagnostic assay, ClonoSEQ.
Trending:
-
![UK ramps up effort to improve asthma diagnosis]()
UK ramps up effort to improve asthma diagnosis
-
![Google, Verily initiate AI screening programme for eye conditions in India]()
Google and Verily initiate AI screening programme for eye conditions
-
![]()
Could MS be diagnosed with a simple blood test?
-
![Biomarker technology]()
The high-tech hunt for new biomarkers
-
![]()
The critical moment: can machine learning save lives in sepsis care?
-
![]()
Artificial intelligence predicts ovarian cancer patients’ survival rate
Most Read
- US agencies collaborate on emergency diagnostics task force
- UK ramps up effort to improve asthma diagnosis
- New leukaemia test can predict how patient will respond to therapy
- Google and Verily initiate AI screening programme for eye conditions
- Lab-on-a-chip device to use liquid biopsy to detect cancer quickly
Company A-Z
Latest Content
Oxford BioDynamics to assess EpiSwitch in prostate cancer trial
UK-based biotechnology company Oxford BioDynamics has partnered with Imperial College London to test its EpiSwitch biomarker assay in the PROSTAGRAM trial for prostate cancer diagnosis.
ABL to distribute TGen’s new TB test
The Translational Genomics Research Institute (TGen) in the US has signed a licensing agreement with integrated diagnostics firm Advanced Biological Laboratories (ABL) to market its tuberculosis (TB) test technology.
New dopamine sensor could help detect brain disorders rapidly
University of Central Florida (UCF) researchers have developed a rapid detector for dopamine that could help diagnose brain conditions such as Parkinson’s disease and depression.
What does the anti-vaxxer movement mean for the vaccination market?
The World Health Organization estimates that 2–3 million lives are saved every year through vaccination.
EPIQ CVx Cardiovascular Ultrasound System
The EPIQ CVx is a software-controlled diagnostic cardiovascular ultrasound system developed by Philips based on the company’s Anatomical Intelligence Ultrasound (AIUS) platform.
Researchers develop new test for prostate cancer
An international research team led by University College Dublin (UCD) in Ireland has developed epiCaPture, a new test that detects prostate cancer using urine samples.
Ohio State researchers identify biomarkers of fibromyalgia
Researchers from Ohio State University have identified the specific biomarkers of fibromyalgia, differentiating it from other related diseases.
Researchers use molecular patterns to predict breast cancer recurrence
A study has revealed that understanding the genetic and molecular structure of individual breast tumours could provide information on cancer progression and recurrence.
Study finds AI could reduce false positives in lung cancer screening
A study by a research team in the US has found that artificial intelligence (AI) technology could substantially cut false positives while screening for lung cancer.
US researchers develop blood test to monitor stress intensity
Researchers at Indiana University School of Medicine in the US have discovered a blood test that could track stress intensity and help diagnose people suffering from post-traumatic stress disorder (PTSD).
Latest News
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.
Go Top
